NCT05152095

Brief Summary

This is a sham-controlled randomized trial to identify the effectiveness of treating insomnia induced by anxiety with self-administered auricular acupressure in Malaysia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 13, 2021

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

December 1, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 9, 2021

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
Last Updated

December 30, 2021

Status Verified

December 1, 2021

Enrollment Period

2 months

First QC Date

December 1, 2021

Last Update Submit

December 10, 2021

Conditions

Keywords

auricular acupressureinsomniaanxietyrandomized sham controlled trial

Outcome Measures

Primary Outcomes (4)

  • Insomnia Severity Index (ISI)

    Total score categories: 0-7 = No clinically significant insomnia 8-14 = Subthreshold insomnia 15-21 = Clinical insomnia (moderate severity) 22-28 = Clinical insomnia (severe)

    6th day

  • Insomnia Severity Index (ISI)

    Total score categories: 0-7 = No clinically significant insomnia 8-14 = Subthreshold insomnia 15-21 = Clinical insomnia (moderate severity) 22-28 = Clinical insomnia (severe)

    11th day

  • Hamilton Anxiety Rating Scale (HAM-A)

    Total score range of 0-56, where \<17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe.

    6th day

  • Hamilton Anxiety Rating Scale (HAM-A)

    Total score range of 0-56, where \<17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe.

    11th day

Study Arms (2)

Intervention

EXPERIMENTAL

Self-administered Vaccaria seed tapes on auricular acupoints with pressure applied

Other: Vaccaria seed (Wang Bu Liu Xing) pre-attached to adhesive tape used for auricular acupressure

Sham

SHAM COMPARATOR

Self-administered plain tapes (without Vaccaria seed) on auricular acupoints without applying pressure.

Other: Plain ear adhesive tape

Interventions

Apply on auricular acupoints, Shenmen and Occiput, apply pressure for 3 minutes, 5 times per day, at the interval of 2 \~ 3 hours, for 5 days.

Intervention

Apply on Shenmen and Occiput without applying pressure for 5 days.

Sham

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All Malaysian aged above 18 years old who are suffering from chronic insomnia based on International Classification of Sleep Disorders 3(ICSD-3) and with Insomnia Severity Index (ISI) of 18 and above and more than 3 months.
  • Willing to comply with the recommended periodic acupressure stimulation every day during the 1 week period.

You may not qualify if:

  • Subject with insomnia score below 18 based on Insomnia Severity Index (ISI).
  • Subject with stress and anxiety level below 18 in the Hamilton Anxiety Rating Scale (HAM-A).
  • Subject with the history of skin sensitivity.
  • Subject who just started on new medication to treat insomnia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

International Medical University (IMU)

Kuala Lumpur, Malaysia

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersAnxiety Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

December 1, 2021

First Posted

December 9, 2021

Study Start

November 13, 2021

Primary Completion

January 1, 2022

Study Completion

January 31, 2022

Last Updated

December 30, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations